 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              A meeting of the Board of Directors of Venus Remedies Ltd is scheduled to be held on 18.03.2017 to allot 9,00,000 equity shares on conversion of fully convertible warrants to Promoters on preferential basis and any other item with the permission of chair.
The trading window shall be closed for the dealing in the securities of the company listed at your exchange with effect from March 15, 2017 to March 20, 2017 (both days inclusive) for all the Directors, Designated employees and other insiders in view of the aforesaid Board meeting.
Shares of VENUS REMEDIES LTD. was last trading in BSE at Rs.98.2 as compared to the previous close of Rs. 98.75. The total number of shares traded during the day was 10875 in over 175 trades.
The stock hit an intraday high of Rs. 99.3 and intraday low of 97. The net turnover during the day was Rs. 1068780.